Financial Performance - Net income for the three months ended March 31, 2025, was $255 million, a slight increase from $254 million in the same period in 2024[230]. - Total premium income rose 5% to $1.2 billion for the three months ended March 31, 2025, compared to the prior year[243]. - Net operating income decreased 2% to $259 million, impacted by an 18% decline in excess investment income[231]. - Total net sales increased 6% to $216 million, with an average producing agent count rising 5% over the prior year[228]. - For the three months ended March 31, 2025, total premium and policy charges increased by 3% to $829.9 million compared to $804.3 million in the same period of 2024[255]. - Total health net sales for the three months ended March 31, 2025, were $67.237 million, a 24% increase from $54.400 million in the same period in 2024[300]. Premium Income - Life insurance premium income increased 3% to $830 million, while life underwriting margin increased to $337 million, up 9% from $309 million in 2024[244]. - Health insurance premium income increased 8% to $370 million, but health underwriting margin declined to $85 million, down 10% from $94 million in 2024[245]. - Health premium accounted for 31% of total premium in 2025, while the health underwriting margin declined to $85 million from $94 million in the prior year[284]. - The life insurance segment contributed 69% of total premium and 80% of total underwriting margin in 2025[253]. Investment Income - Excess investment income declined 18% to $35.9 million, reflecting lower earned yields on investments[246]. - Net investment income for the three months ended March 31, 2025, was $281 million, a 1% decrease from the previous year, while mean invested assets increased by 1%[322]. - The earned yield on commercial mortgage loans decreased to 6.53% from 8.70% in the prior year, attributed to lower floating rates and loans in non-accrual status[322]. - Excess investment income for Q1 2025 was $35.870 million, down 18% from $43.785 million in Q1 2024[318]. Shareholder Returns - The company repurchased 1.5 million shares at a total cost of $177 million, averaging $121.70 per share[247]. - Share repurchases in Q1 2025 totaled $263,170 thousand, significantly higher than $23,529 thousand in Q1 2024, driven by favorable market conditions and higher excess cash flow[386]. - The company has utilized $10.5 billion for share repurchases since the program's inception in 1986, indicating a long-term commitment to returning value to shareholders[383]. Operating Expenses - Total operating expenses increased by $15,532 thousand, or 17%, compared to the same period in 2024, primarily due to higher insurance administrative expenses[380]. - Insurance administrative expenses as a percentage of premium increased to 7.3% for the three months ended March 31, 2025, compared to 7.0% for the same period in 2024[380]. Cash Flow and Liquidity - Consolidated net cash inflows from operations were $432 million in Q1 2025, compared to $351 million in Q1 2024, reflecting a year-over-year increase of approximately 23%[404]. - Cash and short-term investments increased to $366 million at March 31, 2025, up from $250 million at December 31, 2024[405]. - The company expects to maintain target capital ratios through liquid assets, internally-generated cash flow, and the credit facility[403]. - The company has $17.5 billion in fixed income securities available for sale, providing a buffer for unexpected liquidity needs[405]. Investment Strategy - Globe Life's investment strategy focuses on high-quality fixed maturities, with a significant portion of the portfolio consisting of investment-grade securities[339]. - The company plans to continue executing its investment strategy by seeking assets that meet quality objectives while maximizing risk-adjusted returns[345]. - The total fixed maturity portfolio had a fair value of $17.5 billion, an increase from $17.2 billion at December 31, 2024[366]. Debt and Financing - The total long-term debt remained stable at $2.3 billion as of March 31, 2025, consistent with the previous reporting period[406]. - The annualized interest rate on commercial paper was 5.13% as of March 31, 2025, slightly down from 5.22% at December 31, 2024[400]. - The Parent Company had $476 million of additional borrowing capacity under its credit facility as of March 31, 2025, down from $561 million a year earlier[400].

Core Insights - Globe Life Inc. reported a first-quarter 2025 net operating income of $3.07 per share, which missed the Zacks Consensus Estimate by 5.2%, but improved 10% year over year due to higher insurance underwriting income [1] - The company experienced a 5% year-over-year increase in total premium revenues, reaching $1.2 billion, primarily driven by higher premiums from Life and Health insurance [2] - Net investment income decreased by 1% year over year to $280.6 million, while operating revenues rose 3.7% to $1.5 billion, attributed to growth in Life and Health insurance premiums [2] Financial Performance - Excess investment income, a profitability measure, fell 18% year over year to $35.8 million, while total insurance underwriting income increased by 4% to $336.3 million, mainly due to higher Life underwriting income [3] - Total benefits and expenses rose 5.7% year over year to $1.1 billion, driven by increased policyholder benefits and various operational costs [4] - Administrative expenses increased by 8.8% year over year to $87.5 million [3] Segmental Results - Life insurance premium revenues grew by 3% year over year to $829.8 million, supported by higher premiums from distribution channels like American Income and Liberty National, both of which grew by 6% [5] - Health insurance premium revenues increased by 8% year over year to $369.7 million, with net health sales rising 24% to $67.2 million, although underwriting margins decreased by 10% [6] Shareholder Information - As of March 31, 2025, shareholders' equity, excluding accumulated other comprehensive income (AOCI), decreased by 1.5% year over year to $7.4 billion, while book value per share, excluding AOCI, increased by 11.2% to $87.92 [7] - The operating return on equity, excluding AOCI, was 14.3%, contracting by 30 basis points year over year [7] Share Repurchase - Globe Life repurchased 1.5 million shares worth $177 million during the reported quarter [9] Future Outlook - The company projects net operating income between $13.45 and $14.05 per diluted common share for the year ending December 31, 2025, reaffirming earlier guidance [10]

Financial Data and Key Metrics Changes - In Q1 2025, net income was $255 million or $3.01 per share, compared to $254 million or $2.67 per share a year ago, indicating a year-over-year increase in earnings per share [6] - Net operating income for the quarter was $259 million or $3.07 per share, a 10% increase from the previous year [6] - Return on equity as of March 31 was 19%, with book value per share at $64.5, while excluding accumulated other comprehensive income (AOCI), return on equity was 14.1% and book value per share was $87.92, up 11% from a year ago [6] Business Line Data and Key Metrics Changes - Life insurance operations saw premium revenue increase by 3% to $830 million, with life underwriting margin rising 9% to $337 million due to premium growth and lower policy obligations [6][7] - Health insurance premium revenue grew 8% to $370 million, but health underwriting margin decreased by 10% to $85 million due to higher claim costs [7] - American Income Life reported a 6% increase in life premiums to $438 million, with a life underwriting margin up 5% to $196 million [9] - Liberty National's life premiums grew 6% to $96 million, while Family Heritage's health premiums increased 9% to $112 million [11][12] Market Data and Key Metrics Changes - The average producing agent count for American Income Life was 11,510, up 3% from a year ago, while Liberty National's agent count increased by 8% to 3,688 [9][11] - Direct to consumer life premiums decreased by 1% to $246 million, with net life sales down 12% to $25 million due to reduced marketing spend [12] - United American General Agency's health premiums increased by 13% to $160 million, but health underwriting margin fell to $2 million due to higher claim costs [13] Company Strategy and Development Direction - The company expects life premium revenue to grow around 4% for the year, with health premium revenue anticipated to grow between 7.5% and 8.5% [7] - The company plans to maintain a conservative investment philosophy, focusing on long-dated assets to withstand economic downturns [24] - The company is evaluating capital management opportunities under an economic framework available in Bermuda, with updates expected in 2025 [30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving the midpoint of EPS guidance for 2025, citing favorable mortality trends and expected remeasurement gains [44] - The company anticipates a favorable margin impact in the third quarter due to life assumption updates, with expected remeasurement gains between $60 million and $100 million [33] - Management acknowledged challenges in health margins due to increased claims but remains optimistic about managing these through rate increases [52] Other Important Information - The company repurchased approximately 1.5 million shares for $177 million in Q1 2025, returning a total of $197 million to shareholders [26] - The company has a consolidated risk-based capital (RBC) ratio of 316%, providing excess capital to meet minimum target levels [29] - Legal proceedings included an estimate for settlements related to outstanding litigation, not directly tied to ongoing regulatory matters [78] Q&A Session Summary Question: What is the outlook for health margins? - Management indicated that most rate increases will be effective at the beginning of Q2, expecting margins for United American General Agency to be in the 5% to 7% range for the year [37][38] Question: How confident is the company in achieving EPS guidance? - Management expressed confidence in the guidance range, citing favorable mortality trends and expected remeasurement gains [44][46] Question: What is driving the increase in health usage? - The increase in health usage is primarily frequency-driven, with some claims related to specialty bandages contributing to higher costs [97]

Financial Data and Key Metrics Changes - In Q1 2025, net income was $255 million or $3.01 per share, compared to $254 million or $2.67 per share a year ago, indicating a slight increase in profitability [5] - Net operating income for the quarter was $259 million or $3.07 per share, a 10% increase from the previous year, slightly exceeding internal projections [5] - Return on equity as of March 31 was 19%, with book value per share at $64.5, while excluding accumulated other comprehensive income (AOCI), return on equity was 14.1% and book value per share was $87.92, up 11% from a year ago [5] Business Line Data and Key Metrics Changes - Life insurance premium revenue increased by 3% year-over-year to $830 million, with life underwriting margin rising 9% to $337 million due to premium growth and lower policy obligations [5][6] - Health insurance premium revenue grew by 8% to $370 million, but health underwriting margin decreased by 10% to $85 million due to higher claim costs [6] - American Income Life saw life premiums rise 6% to $438 million, with a life underwriting margin up 5% to $196 million [8] - Liberty National's life premiums grew 6% to $96 million, while health sales decreased by 5% to $7 million [10] - Family Heritage's health premiums increased by 9% to $112 million, with health underwriting margin up 10% to $39 million [11] Market Data and Key Metrics Changes - United American General Agency's health premiums increased by 13% to $160 million, but health underwriting margin fell to $2 million due to higher claim costs [13] - The average producing agent count across various divisions showed growth, with American Income up 3% and Liberty National up 8% year-over-year [9][10] Company Strategy and Development Direction - The company anticipates life premium revenue growth of around 4% for the year, with health premium revenue expected to grow between 7.5% and 8.5% [6] - The focus remains on managing rising advertising and distribution costs while maximizing underwriting margin dollars on new sales [12] - The company plans to maintain a consolidated risk-based capital (RBC) ratio within the targeted range of 300% to 320% [29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving the midpoint of EPS guidance for 2025, citing favorable mortality trends and expected remeasurement gains [42][44] - The company is well-positioned to manage through economic uncertainties, with a strong capital position and a conservative investment philosophy [24][29] - There is an expectation of elevated health obligations due to recent claim trends, but management believes they can manage these through rate increases [33] Other Important Information - The company repurchased approximately 1.5 million shares for $177 million in Q1 2025, returning a total of $197 million to shareholders [26] - Legal proceedings included an estimate for settlements related to outstanding litigation, but these are not indicative of future performance [78] Q&A Session Summary Question: Outlook for Health margins and timing of rate actions - Management indicated that most rate increases will be effective at the beginning of Q2, expecting margins for UAGA to be in the 5% to 7% range for the year [36] Question: Confidence in EPS guidance amid tough comps - Management reaffirmed confidence in the EPS guidance range, citing favorable mortality trends and expected remeasurement gains [42][44] Question: Increase in health usage and claims - Management noted that utilization is the primary driver of increased claims, with actions being taken to mitigate costs related to specific procedures [96][100] Question: Capital return strategy and commercial paper reduction - The company plans to maintain a normal capital return strategy but may front-load buybacks depending on market conditions [57] Question: Legal proceedings and regulatory matters - The increase in legal expenses is not indicative of future performance and is common in the insurance industry [78]

Core Viewpoint - Globe Life reported quarterly earnings of $3.07 per share, missing the Zacks Consensus Estimate of $3.24 per share, but showing an increase from $2.78 per share a year ago, indicating a -5.25% earnings surprise [1][2] Financial Performance - The company posted revenues of $1.48 billion for the quarter ended March 2025, missing the Zacks Consensus Estimate by 0.52%, compared to $1.4 billion in revenues a year ago [2] - Over the last four quarters, Globe Life has surpassed consensus EPS estimates three times, but has not beaten consensus revenue estimates [2] Stock Performance - Globe Life shares have increased approximately 11.2% since the beginning of the year, contrasting with the S&P 500's decline of -5.5% [3] - The current consensus EPS estimate for the upcoming quarter is $3.39 on revenues of $1.51 billion, and for the current fiscal year, it is $13.67 on revenues of $6.06 billion [7] Industry Outlook - The Insurance - Accident and Health industry is currently in the top 36% of over 250 Zacks industries, suggesting a favorable outlook as the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

[First Quarter 2025 Financial Performance Overview](index=1&type=section&id=First%20Quarter%202025%20Results) [Results of Operations](index=2&type=section&id=RESULTS%20OF%20OPERATIONS) In the first quarter of 2025, Globe Life reported a net income of $3.01 per diluted common share, a 13% increase year-over-year. Net operating income, a key management metric, rose by 10% to $3.07 per diluted common share, exceeding management's expectations. This growth was primarily driven by a 17% increase in insurance underwriting income per share, although partially offset by lower excess investment income and higher interest on debt Q1 2025 Key Per Share Financial Metrics | Metric | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | Net Income per Diluted Share | $3.01 | $2.67 | 13% | | Net Operating Income per Diluted Share | $3.07 | $2.78 | 10% | | Insurance Underwriting Income per Share | $3.98 | $3.41 | 17% | | Excess Investment Income per Share | $0.42 | $0.46 | (9)% | Q1 2025 Operating Summary (in thousands) | Operating Summary | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | Insurance underwriting income | $336,315 | $324,361 | 4% | | Excess investment income | $35,870 | $43,785 | (18)% | | Net operating income | $259,337 | $264,099 | (2)% | | Net income | $254,563 | $254,217 | 0% | - The company incurred costs of **$4.8 million** related to the settlement of certain litigation claims, which impacted net income[7](index=7&type=chunk)[8](index=8&type=chunk) [Reconciliation of GAAP and Non-GAAP Measures](index=3&type=section&id=MANAGEMENT%20VS.%20GAAP%20MEASURES) The company's net income as a return on equity (ROE) was 19.0% for Q1 2025, compared to 21.3% in the prior year. The non-GAAP measure of net operating income as an ROE (excluding AOCI) was 14.1%, slightly down from 14.3%. Book value per share increased significantly to $64.50 from $53.03 year-over-year, while book value per share excluding AOCI, a key management metric, grew to $87.92 from $79.00 Return on Equity (ROE) Comparison | Metric | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Net income as an ROE | 19.0% | 21.3% | | Net operating income as an ROE (excluding AOCI) | 14.1% | 14.3% | Book Value Per Share Comparison | Metric | March 31, 2025 | March 31, 2024 | | :--- | :--- | :--- | | Book value per share | $64.50 | $53.03 | | Book value per share, excluding AOCI | $87.92 | $79.00 | - Management utilizes non-GAAP measures like shareholders' equity excluding AOCI to better identify trends by removing fluctuations from interest rate changes[12](index=12&type=chunk) [Insurance Operations Analysis](index=4&type=section&id=INSURANCE%20OPERATIONS:) [Overall Insurance Performance](index=4&type=section&id=INSURANCE%20UNDERWRITING%20INCOME) Total insurance premium revenue grew 5% year-over-year to $1.2 billion, with life insurance premiums up 3% and health insurance premiums up 8%. Life insurance constitutes 69% of total premium revenue and 80% of the underwriting margin. Overall insurance underwriting income increased by 4% to $336.3 million, while net health sales saw a strong 24% increase, contrasting with a 1% decline in net life sales Q1 Insurance Premium Revenue (in thousands) | Product Type | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | Life insurance | $829,863 | $804,265 | 3% | | Health insurance | $369,791 | $341,019 | 8% | | **Total** | **$1,199,654** | **$1,145,284** | **5%** | Q1 Insurance Underwriting Income (in thousands) | Segment | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | Life Underwriting Margin | $337,264 | $309,011 | 9% | | Health Underwriting Margin | $84,721 | $93,770 | (10)% | | **Insurance Underwriting Income** | **$336,315** | **$324,361** | **4%** | - The ratio of administrative expenses to premium increased to **7.3%** in Q1 2025 from 7.0% in Q1 2024[20](index=20&type=chunk) [Life Insurance Segment](index=5&type=section&id=LIFE%20INSURANCE%20RESULTS%20BY%20DISTRIBUTION%20CHANNEL) Life insurance premiums increased by 3% to $830 million, driven by 6% growth in both the American Income and Liberty National divisions. However, total net life sales declined by 1%, with a notable 12% drop in the Direct to Consumer channel. Despite the mixed sales results, the total life underwriting margin improved by 9% to $337 million, with the margin percentage rising to 41% from 38% Q1 Life Premium by Distribution Channel (in thousands) | Channel | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | American Income | $437,866 | $414,044 | 6% | | Direct to Consumer | $245,600 | $248,040 | (1)% | | Liberty National | $96,182 | $90,777 | 6% | | **Total** | **$829,863** | **$804,265** | **3%** | Q1 Life Net Sales by Distribution Channel (in thousands) | Channel | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | American Income | $98,555 | $97,195 | 1% | | Direct to Consumer | $25,175 | $28,563 | (12)% | | Liberty National | $22,469 | $21,605 | 4% | | **Total** | **$148,351** | **$149,497** | **(1)%** | Q1 Life Underwriting Margin by Distribution Channel (in thousands) | Channel | Q1 2025 | % of Premium | Q1 2024 | % of Premium | % Change | | :--- | :--- | :--- | :--- | :--- | :--- | | American Income | $196,169 | 45% | $187,068 | 45% | 5% | | Direct to Consumer | $64,200 | 26% | $58,585 | 24% | 10% | | **Total** | **$337,264** | **41%** | **$309,011** | **38%** | **9%** | [Health Insurance Segment](index=6&type=section&id=HEALTH%20INSURANCE%20RESULTS%20BY%20DISTRIBUTION%20CHANNEL) Health insurance operations showed strong top-line growth, with premiums up 8% to $370 million and net sales surging 24% to $67 million. The growth was led by the United American division, which saw a 13% increase in premiums and a 69% jump in net sales. Despite this sales momentum, the total health underwriting margin declined by 10% to $84.7 million, with the margin percentage falling to 23% from 27%, primarily due to a significant drop in United American's margin Q1 Health Premium by Distribution Channel (in thousands) | Channel | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | United American | $159,848 | $141,635 | 13% | | Family Heritage | $112,354 | $103,391 | 9% | | **Total** | **$369,791** | **$341,019** | **8%** | Q1 Health Net Sales by Distribution Channel (in thousands) | Channel | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | United American | $27,708 | $16,423 | 69% | | Family Heritage | $26,816 | $24,966 | 7% | | **Total** | **$67,237** | **$54,400** | **24%** | Q1 Health Underwriting Margin by Distribution Channel (in thousands) | Channel | Q1 2025 | % of Premium | Q1 2024 | % of Premium | % Change | | :--- | :--- | :--- | :--- | :--- | :--- | | United American | $1,617 | 1% | $11,906 | 8% | (86)% | | Family Heritage | $39,249 | 35% | $35,838 | 35% | 10% | | **Total** | **$84,721** | **23%** | **$93,770** | **27%** | **(10)%** | [Agent Productivity](index=7&type=section&id=PRODUCING%20EXCLUSIVE%20AGENT%20COUNT%20RESULTS%20BY%20DISTRIBUTION%20CHANNEL) The company saw growth in its exclusive producing agent force compared to the prior year. The average producing agent count at American Income grew by 3% to 11,510. Liberty National and Family Heritage divisions experienced stronger growth, with agent counts increasing by 8% and 9% respectively Quarterly Average Producing Agent Count | Division | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | American Income | 11,510 | 11,139 | 3% | | Liberty National | 3,688 | 3,419 | 8% | | Family Heritage | 1,417 | 1,295 | 9% | [Investment Portfolio and Strategy](index=7&type=section&id=INVESTMENTS) [Investment Performance](index=7&type=section&id=Excess%20Investment%20Income) Excess investment income, a key measure of the investment segment's performance, decreased by 18% to $35.9 million in Q1 2025. On a per-share basis, it fell 9% to $0.42. This decline was driven by a 1% drop in net investment income coupled with a 2% increase in required interest on policy liabilities Q1 Excess Investment Income (in thousands, except per share) | Metric | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | Net investment income | $280,614 | $282,578 | (1)% | | Interest on policy liabilities | ($244,744) | ($238,793) | 2% | | **Excess investment income** | **$35,870** | **$43,785** | **(18)%** | | **Per share** | **$0.42** | **$0.46** | **(9)%** | - The fixed maturity portfolio earned an annual taxable equivalent effective yield of **5.25%** during Q1 2025, stable compared to 5.24% in the year-ago quarter[43](index=43&type=chunk) [Investment Portfolio Composition](index=8&type=section&id=Investment%20Portfolio) As of March 31, 2025, Globe Life's total investment portfolio stood at $20.0 billion. The portfolio is heavily weighted towards fixed maturities, which comprise 87% of the total at fair value. The quality of the fixed maturity portfolio remains high, with 97% of assets rated as 'investment grade' at both amortized cost and fair value Investment Portfolio Composition as of March 31, 2025 (in thousands) | Asset Class | Amount | % of Total | | :--- | :--- | :--- | | Fixed maturities at fair value | $17,504,967 | 87% | | Other long-term investments | $1,236,624 | 6% | | Policy loans | $708,175 | 4% | | Mortgage loans | $426,174 | 2% | | Short-term investments | $134,066 | 1% | | **Total** | **$20,010,006** | | - At amortized cost, **97%** of the **$19.0 billion** fixed maturity portfolio was rated investment grade. Corporate bonds make up the largest portion at **$15.1 billion**[42](index=42&type=chunk)[43](index=43&type=chunk) - The company is not a party to any credit default swaps and does not participate in securities lending[44](index=44&type=chunk) [Investment Acquisitions](index=9&type=section&id=Fixed%20Maturity%20Acquisitions) During the first quarter, the company acquired $244.8 million in fixed maturities, a decrease from $682.4 million in the prior-year quarter. These new investments have an average annual effective yield of 6.4% and an average rating of A-. The company also invested $52.0 million in other assets, primarily mortgage loans and limited partnerships Q1 Fixed Maturity Acquisitions | Metric | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Amount (in thousands) | $244,845 | $682,427 | | Average annual effective yield | 6.4% | 5.9% | | Average rating | A- | A | Q1 Other Investment Acquisitions (in thousands) | Type | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Limited partnerships | $15,831 | $67,498 | | Mortgage loans | $35,621 | $58,406 | | **Total** | **$51,954** | **$139,222** | [Capital Management and Outlook](index=9&type=section&id=SHARE%20REPURCHASE:) [Share Repurchase and Liquidity](index=9&type=section&id=LIQUIDITY/CAPITAL:) Globe Life continued its capital return program by repurchasing 1.5 million shares of its common stock for a total of $177 million during the quarter, at an average price of $121.70 per share. The company reports that its operations generate strong, stable cash flows, ensuring sufficient liquidity at the Parent Company level to meet the capital needs of its insurance subsidiaries - In Q1 2025, the company repurchased **1.5 million** common shares[50](index=50&type=chunk) - The total cost of the share repurchase was **$177 million**, at an average price of **$121.70 per share**[50](index=50&type=chunk) - The company's primary business of writing basic protection life and supplemental health insurance generates strong and stable cash flows, which are not impacted by volatile equity markets[51](index=51&type=chunk) [2025 Earnings Guidance](index=9&type=section&id=EARNINGS%20GUIDANCE%20FOR%20THE%20YEAR%20ENDING%20DECEMBER%2031,%202025:) Globe Life has reaffirmed its full-year 2025 earnings guidance. The company continues to project net operating income to be in the range of $13.45 to $14.05 per diluted common share - The company reaffirmed its previous guidance for the full year ending December 31, 2025[52](index=52&type=chunk) - Projected net operating income per diluted common share for 2025 is between **$13.45** and **$14.05**[52](index=52&type=chunk) [Appendix](index=12&type=section&id=APPENDIX) [GAAP Condensed Consolidated Statements of Operations](index=12&type=section&id=GLOBE%20LIFE%20INC.%20GAAP%20CONDENSED%20CONSOLIDATED%20STATEMENTS%20OF%20OPERATIONS) The GAAP condensed consolidated statement of operations shows total revenues of $1.48 billion for Q1 2025, an increase from $1.42 billion in Q1 2024. Net income remained flat at approximately $254 million for both periods. On a per-share basis, diluted net income was $3.01, up from $2.67 in the prior-year quarter Q1 GAAP Condensed Consolidated Statements of Operations (in thousands) | Metric | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Total premium | $1,199,654 | $1,145,284 | | Total revenue | $1,480,422 | $1,416,139 | | Total benefits and expenses | $1,164,341 | $1,101,216 | | Income before income taxes | $316,081 | $314,923 | | **Net income** | **$254,563** | **$254,217** | | **Diluted net income per common share** | **$3.01** | **$2.67** |

Core Insights - Value investing remains a preferred strategy for identifying strong stocks across various market conditions, focusing on companies perceived as undervalued based on fundamental analysis [2] - Zacks has developed a Style Scores system to highlight stocks with specific traits, particularly beneficial for value investors seeking stocks with high grades in the "Value" category [3] Company Analysis: Globe Life (GL) - Globe Life (GL) holds a Zacks Rank of 2 (Buy) and a Value grade of A, indicating strong potential for value investors [4] - The stock's Forward P/E ratio is 8.68, significantly lower than the industry's average of 13.86, with a 52-week range of 4.15 to 10.58 [4] - Globe Life's P/B ratio stands at 1.94, compared to the industry's average of 2.56, with a 52-week range of 0.92 to 2.61 [5] - The P/CF ratio for Globe Life is 7.01, which is attractive relative to the industry's average of 15.05, with a 52-week range of 3.39 to 8.79 [6] - These valuation metrics suggest that Globe Life is likely undervalued, supported by a strong earnings outlook, making it an impressive value stock [7]

Core Insights - Globe Life's Q4 2024 net operating income was $3.14 per share, exceeding estimates by 1.3% and showing a 12% year-over-year improvement driven by higher investment and underwriting income [2] - Total operating revenues for Q4 reached $1.4 billion, a 4.4% increase from the previous year, although it missed estimates by 1% [2] - The company reported a total premium revenue of $1.18 billion, up 4.5% year over year, primarily from life and health insurance premiums [3] Financial Performance - Net investment income rose 4% year over year to $282.4 million, while excess investment income increased by 7% to $38.3 million [3] - Total insurance underwriting income grew 3.1% year over year to $337.9 million, attributed to improved life underwriting income [4] - Administrative expenses increased by 18.3% year over year to $91.4 million, contributing to a total benefits and expenses rise of 7% to $1.1 billion [4] Segment Analysis - Life insurance premium revenues increased by 4% year over year to $822.9 million, with net sales rising 11% to $144.9 million [5] - Health insurance premium revenues grew by 7% year over year to $358.3 million, with net health sales increasing by 6% to $73.6 million [6] Shareholder Metrics - Shareholders' equity, excluding AOCI, increased by 1% year over year to $7.34 billion, with book value per share rising 13.4% to $86.40 [7] - The net operating return on equity, excluding AOCI, was 15.1%, expanding by 40 basis points year over year [7] Share Repurchase Activity - Globe Life repurchased 0.33 million shares worth $36 million during the reported quarter [8] Full-Year Performance - For the full year 2024, net operating income was $12.37 per share, a 16% increase year over year, with total operating revenues rising 5.2% to $5.8 billion [10] Future Outlook - The company estimates net operating income for 2025 to be in the range of $13.45-$14.05 per diluted common share [11] - Recent estimates have trended upward, indicating a positive outlook for the stock, which holds a Zacks Rank 2 (Buy) [12][14]